AstraZeneca

AstraZeneca’s TAGRISSO Combo Shows Strong Survival Benefit in EGFR-Mutated Lung Cancer

WILMINGTON, DE — AstraZeneca announced that its lung cancer therapy TAGRISSO® (osimertinib), when used in combination with chemotherapy, delivered a statistically significant and clinically meaningful improvement in overall survival for patients …

AstraZeneca’s TAGRISSO Combo Shows Strong Survival Benefit in EGFR-Mutated Lung Cancer Read More


Triumph

Triumph Group Completes Sale to Warburg Pincus and Berkshire Partners, Taps Former TransDigm COO as CEO

RADNOR, PA — Triumph Group, Inc. (NYSE: TGI), a leading aerospace and defense systems supplier, has officially transitioned to private ownership following its acquisition by private equity firms Warburg Pincus and …

Triumph Group Completes Sale to Warburg Pincus and Berkshire Partners, Taps Former TransDigm COO as CEO Read More